文献速递心血管胸部US

肺血管扩张剂治疗肺动脉高压随访中基线与纵向评估的相对重要性

Relative Importance of Baseline and Longitudinal Evaluation in the Follow-Up of Vasodilator Therapy in Pulmonary Arterial Hypertension.
PubMed 文献 · JACC Cardiovasc Imaging · 2018-10-17

在162例前瞻性招募的肺动脉高压患者中,96例有≥3次连续超声心动图检查者纳入分析,评估基线与随访时肺动脉收缩压和右心室功能对全因死亡的预测价值。基线右心室游离壁应变是独立预测因子(HR 0.90,95%CI 0.83–0.97,p=0.007),随访期间各参数变化微小,仅右心室游离壁应变、右房面积和下腔静脉的变化与结局相关。

要点

  • 基线右心室游离壁应变是肺动脉高压患者全因死亡的独立预测因子,独立于肺动脉收缩压。
  • 随访期间右心室功能与肺动脉收缩压变化微小,死亡者与存活者间随访参数无显著差异。
  • 校正基线值与随访时间后,右心室游离壁应变、右房面积和下腔静脉的变化可预测结局。

核心结论

  • 在肺动脉高压中,基线右心室功能(右心室游离壁应变)是结局的强预测因子,独立于肺动脉收缩压;治疗过程中变化似乎微小,仅右心室游离壁应变、下腔静脉、大小和右房面积的变化与结局相关。

研究设计与样本

  • 前瞻性招募162例肺动脉高压患者,其中96例有≥3次连续超声心动图检查者纳入本分析;基线与随访时用二维超声心动图测量肺动脉收缩压和右心室功能(包括右心室游离壁应变);采用单变量和多变量Cox回归嵌套模型确定全因死亡的增量与独立预测因子。

关键影像表现/征象

  • 随访期间各参数变化微小:右心室游离壁应变p=0.46,右心室舒张末期面积p=0.48,三尖瓣环收缩期位移p=0.32,肺动脉收缩压p=0.66,右房面积p=0.39,下腔静脉p=0.25。
  • 死亡者随访间右心室游离壁应变(p=0.50)、肺动脉收缩压(p=0.90)和三尖瓣环收缩期位移(p=0.83)无差异。

诊断标准与关键数值

  • 基线右心室游离壁应变为全因死亡的独立预测因子:HR 0.90(95%CI 0.83–0.97,p=0.007),增量于肺动脉收缩压和其他临床协变量(C统计量=0.74,p=0.001)。
  • 校正基线测量和随访时间后,随访期间右心室游离壁应变平均变化(HR 0.78,95%CI 0.63–0.96,p=0.002)、右房面积(HR 1.20,95%CI 1.07–1.40,p=0.003)和下腔静脉(HR 66.5,95%CI 8.5–520.5,p<0.001)可显著预测结局。

临床应用与阅片要点

  • 在肺动脉高压患者随访中,基线右心室游离壁应变可用于风险分层,独立于肺动脉收缩压。
  • 随访期间右心室游离壁应变、右房面积和下腔静脉的变化与结局相关,死亡者随访间右心室功能与肺动脉收缩压无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to evaluate the relative value of baseline and follow-up echocardiographic assessment of pulmonary artery systolic pressure (PASP) and right ventricular (RV) function in assessing response to vasodilator therapy in pulmonary arterial hypertension (PAH).

BACKGROUND: Routine follow-up of PASP and RV function is widely obtained in patients undergoing treatment for PAH, but the value of this reassessment is uncertain.

METHODS: Of 162 prospectively recruited patients with PAH, 96 were included in this analysis of patients with ≥3 sequential echocardiographic studies. PASP and RV function (including right ventricular free wall strain [RVFWS]) were measured at baseline and on follow-up 2-dimensional echocardiography. Univariate and multivariate Cox regression with nested models was used to determine incremental and independent predictors of all-cause mortality.

RESULTS: Changes between visits were minimal for all parameters (RVFWS, p = 0.46; RV end diastolic area, p = 0.48; tricuspid annular plane systolic excursion, p = 0.32; PASP, p = 0.66; right atrial area, p = 0.39; and inferior vena cava, p = 0.25). Over 3 years of follow-up, 29 patients died. Baseline RVFWS was an independent predictor of outcome (hazard ratio [HR]: 0.90; 95% confidence interval [CI]: 0.83 to 0.97; p = 0.007), incremental to PASP and other clinical covariates (C statistic = 0.74, p = 0.001). Those who died showed no differences in RVFWS (p = 0.50), PASP (p = 0.90), and tricuspid annular plane systolic excursion (p = 0.83) between visits. When baseline measures and follow-up time were accounted for, mean changes in RVFWS (HR: 0.78; 95% CI: 0.63 to 0.96; p = 0.002), right atrial area (HR: 1.20; 95% CI: 1.07 to 1.40; p = 0.003), and inferior vena cava (HR: 66.5; 95% CI: 8.5 to 520.5; p < 0.001) over follow-up were significant in predicting outcome.

CONCLUSIONS: In PAH, baseline RV function (RVFWS) is a strong predictor of outcome, independent of PASP. Changes throughout therapy appear minimal, and only changes in RVFWS, inferior vena cava, size, and right atrial area were associated with outcome.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Wright L, Dwyer N, Wahi S, et al. Relative Importance of Baseline and Longitudinal Evaluation in the Follow-Up of Vasodilator Therapy in Pulmonary Arterial Hypertension. JACC Cardiovasc Imaging. 2018. PMID: 30343091. doi:10.1016/j.jcmg.2018.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。